Missing/wrong data?
Log in to edit
Bim and Bad mediate imatinib-induced killing of Bcr/Abl+ leukemic cells, and resistance due to their loss is overcome by a BH3 mimetic.
scholarly article
Author/s
author: Hamsa Puthalakath, Mark S Cragg, Philippe Bouillet, David C Huang, Oliver Ottmann, Brian Druker, Andrew W. Roberts, Andreas Strasser, Junya Kuroda, Priscilla Kelly
Work details
Publication date
September 22, 2006
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.